US2010316630A1PendingUtilityA1
Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
Est. expiryNov 13, 2023(expired)· nominal 20-yr term from priority
A61P 35/00A61P 37/04C07K 16/4266
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention features anti-idiotype antibodies of the human monoclonal antibody SC-1, as well as methods for producing and using the anti-idiotype antibodies.
Claims
exact text as granted — not AI-modified1 . A method of generating an immune response in a mammal against an anti-idiotype body expressed by the hybridoma cell line with DSMZ accession number DSM ACC2625, said method comprising immunizing said mammal with the purified anti-idiotype antibody expressed by the hybridoma cell line with DSMZ accession number DSM ACC2625.
2 . The method of claim 1 , wherein said anti-idiotype antibody is humanized prior to immunizing said mammal.
3 . The method of claim 1 , wherein said mammal is a non-human mammal.
4 . The method of claim 1 , wherein said immunizing results in cells in said mammal expressing polypeptides that specifically bind to said anti-idiotype antibody.
5 . The method of claim 4 , wherein said polypeptides are antibodies.
6 . The method of claim 5 , wherein said method further comprises isolating said cells expressing said polypeptides from said mammal.
7 . The method of claim 6 , wherein said method further comprises fusing said cells to myeloma cells to generate an antibody-expressing hybridoma cell.
8 . The method of claim 7 , wherein said method further comprises testing whether said hybridoma cell expresses an antibody that specifically binds the anti-idiotype antibody.Join the waitlist — get patent alerts
Track US2010316630A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.